Nimesulide is a prescription non-steroidal anti-inflammatory drug with a multifactorial mode of action, characterized by a fast onset of analgesic activity.It must be used un
der supervision by a doctor in accordance with the approved indications and in compliance with the recommendations included in the Summary of Product Characteristics.
In 1980 the original nimesulide molecule was in-licensed by Helsinn Healthcare, a pharmaceutical company based in Switzerland. In 1985 it was first launched in Italy by Helsinn's local licensees under the brand names Aulin and Mesulid.
Helsinn manufactures the original Nimesulide active ingredient and finished products in full compliance with the current Good Manufacturing Practice (cGMP) guidelines in its plants in Switzerland and Ireland.